
Investors File Securities Fraud Lawsuit Against GeneDx Holdings Corp.
A federal class action lawsuit has been initiated against GeneDx Holdings Corp. following a sharp decline in the company's share price. Investors who purchased WGS common stock between April 16, 2025, and May 4, 2026, are now eligible to seek lead plaintiff status in the case, which centers on alleged misrepresentations regarding an acquisition.
























